Epigallocatechin-3-gallate: a useful, effective and safe clinical approach for targeted prevention and individualised treatment of neurological diseases?

Aquaporin 4-specific T cells in neuromyelitis optica exhibit a Th17 bias and recognizeClostridiumABC transporter

(2012) Michel Varrin-Doyer et al.   ANNALS OF NEUROLOGY

Multiple Sclerosis Lesions and Irreversible Brain Tissue Damage

(2012) Tim Sinnecker et al.   ARCHIVES OF NEUROLOGY

Failure of Natalizumab to Prevent Relapses in Neuromyelitis Optica

(2012) Ingo Kleiter   ARCHIVES OF NEUROLOGY

P02.26. Integrative care for adolescent mood problems: brief report from a second opinion clinic

(2012) K Kemper et al.   BMC Complementary and Alternative Medicine

Amyotrophic lateral sclerosis

(2012) Albert C. Ludolph et al.   CURRENT OPINION IN NEUROLOGY

Quantitative evaluation of the beneficial effects in the mdx mouse of epigallocatechin gallate, an antioxidant polyphenol from green tea

(2012) Yoshiko Nakae et al.   HISTOCHEMISTRY AND CELL BIOLOGY

Epigallocatechin gallate, cerebral blood flow parameters, cognitive performance and mood in healthy humans: a double-blind, placebo-controlled, crossover investigation

(2012) Emma L. Wightman et al.   HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL

Pharmacokinetics and Blood–Brain Barrier Penetration of (+)-Catechin and (−)-Epicatechin in Rats by Microdialysis Sampling Coupled to High-Performance Liquid Chromatography with Chemiluminescence Detection

(2012) Liang Wu et al.   JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY

Dual Role of Selected Antioxidants Found in Dietary Supplements: Crossover between Anti- and Pro-Oxidant Activities in the Presence of Copper

(2012) Jun-Jie Yin et al.   JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY

Green Tea Polyphenols Precondition against Cell Death Induced by Oxygen-Glucose Deprivation via Stimulation of Laminin Receptor, Generation of Reactive Oxygen Species, and Activation of Protein Kinase Cϵ

(2012) Usha Gundimeda et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients

(2012) Sven Jarius et al.   Journal of Neuroinflammation

Dynamics of saccade parameters in multiple sclerosis patients with fatigue

(2012) Carsten Finke et al.   JOURNAL OF NEUROLOGY

Does fingolimod in multiple sclerosis patients cause macular edema?

(2012) Kiran Turaka et al.   JOURNAL OF NEUROLOGY

Testing for antibodies to human aquaporin-4 by ELISA: Sensitivity, specificity, and direct comparison with immunohistochemistry

(2012) S. Jarius et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Prolonged and symptomatic bradycardia following a single dose of fingolimod

(2012) Hans Faber et al.   Multiple Sclerosis Journal

Sudden unexpected death on fingolimod

(2012) JW Lindsey et al.   Multiple Sclerosis Journal

Vitamin D and multiple sclerosis: an interaction between genes and environment

(2012) Adam E Handel et al.   Multiple Sclerosis Journal

Systematic review of disease-modifying therapies to assess unmet needs in multiple sclerosis: tolerability and adherence

(2012) G Giovannoni et al.   Multiple Sclerosis Journal

Does interferon beta treatment exacerbate neuromyelitis optica spectrum disorder?

(2012) Su-Hyun Kim et al.   Multiple Sclerosis Journal

Rituximab dosing and monitoring strategies in neuromyelitis optica patients: creating strategies for therapeutic success

(2012) Benjamin M Greenberg et al.   Multiple Sclerosis Journal

Protective effect of an elastase inhibitor in a neuromyelitis optica-like disease driven by a peptide of myelin oligodendroglial glycoprotein

(2012) Katja Herges et al.   Multiple Sclerosis Journal

Risk stratification for progressive multifocal leukoencephalopathy in patients treated with natalizumab

(2012) Per Soelberg Sørensen et al.   Multiple Sclerosis Journal

Vitamin D und Multiple Sklerose

(2012) A. Döring et al.   NERVENARZT

Impact of epigallo catechin-3-gallate on acetylcholine-acetylcholine esterase cycle in aged rat brain

(2012) Ravichandran Srividhya et al.   NEUROCHEMISTRY INTERNATIONAL

Higher macular volume in patients with MS receiving fingolimod: Positive outcome or side effect?

(2012) M. Dinkin et al.   NEUROLOGY

The ALS-FTD-Q: A new screening tool for behavioral disturbances in ALS

(2012) J. Raaphorst et al.   NEUROLOGY

No MRI evidence of cortical lesions in neuromyelitis optica

(2012) M. Calabrese et al.   NEUROLOGY

Amyotrophic lateral sclerosis, frontotemporal lobar dementia, and p62: A functional convergence?

(2012) S. H. Appel et al.   NEUROLOGY

Frontal lobe abnormalities on MRS correlate with poor letter fluency in ALS

(2012) C. Quinn et al.   NEUROLOGY

SQSTM1 mutations in frontotemporal lobar degeneration and amyotrophic lateral sclerosis

(2012) E. Rubino et al.   NEUROLOGY

Does natalizumab therapy worsen neuromyelitis optica?

(2012) A. Jacob et al.   NEUROLOGY

Distinct lesion morphology at 7-T MRI differentiates neuromyelitis optica from multiple sclerosis

(2012) T. Sinnecker et al.   NEUROLOGY

Fingolimod-associated macular edema: Incidence, detection, and management

(2012) N. Jain et al.   NEUROLOGY

Iron Accumulation in Deep Cortical Layers Accounts for MRI Signal Abnormalities in ALS: Correlating 7 Tesla MRI and Pathology

(2012) Justin Y. Kwan et al.   PLoS One

Adult Neurogenesis Transiently Generates Oxidative Stress

(2012) Noah M. Walton et al.   PLoS One

Evaluation of a Multiparametric Immunofluorescence Assay for Standardization of Neuromyelitis Optica Serology

(2012) Letizia Granieri et al.   PLoS One

Mitoxantrone Induces Natural Killer Cell Maturation in Patients with Secondary Progressive Multiple Sclerosis

(2012) Coralie Chanvillard et al.   PLoS One

Microglial Activation Correlates with Disease Progression and Upper Motor Neuron Clinical Symptoms in Amyotrophic Lateral Sclerosis

(2012) Johannes Brettschneider et al.   PLoS One

The Cortical Signature of Amyotrophic Lateral Sclerosis

(2012) Federica Agosta et al.   PLoS One

Grey and White Matter Changes across the Amyotrophic Lateral Sclerosis-Frontotemporal Dementia Continuum

(2012) Patricia Lillo et al.   PLoS One

A Spirulina-Enhanced Diet Provides Neuroprotection in an α-Synuclein Model of Parkinson's Disease

(2012) Mibel M. Pabon et al.   PLoS One

Incidence of therapy-related acute leukaemia in mitoxantrone-treated multiple sclerosis patients in Germany

(2012) Anke Stroet et al.   Therapeutic Advances in Neurological Disorders

Expert recommendations to personalization of medical approaches in treatment of multiple sclerosis: an overview of family planning and pregnancy

(2012) Nadja Borisow et al.   EPMA Journal

General Report & Recommendations in Predictive, Preventive and Personalised Medicine 2012: White Paper of the European Association for Predictive, Preventive and Personalised Medicine

(2012) Olga Golubnitschaja et al.   EPMA Journal

Epigallocatechin-3-Gallate Ameliorates Experimental Autoimmune Encephalomyelitis by Altering Balance among CD4+ T-Cell Subsets

(2011) Junpeng Wang et al.   AMERICAN JOURNAL OF PATHOLOGY

Neutrophil protease inhibition reduces neuromyelitis optica-immunoglobulin G-induced damage in mouse brain

(2011) Samira Saadoun et al.   ANNALS OF NEUROLOGY

Primary retinal pathology in multiple sclerosis as detected by optical coherence tomography

(2011) A. U. Brandt et al.   BRAIN

Epigallocatechin gallate ameliorates behavioral and biochemical deficits in rat model of load-induced chronic fatigue syndrome

(2011) Anand Kamal Sachdeva et al.   BRAIN RESEARCH BULLETIN

EGCG Ameliorates the Suppression of Long-Term Potentiation Induced by Ischemia at the Schaffer Collateral-CA1 Synapse in the Rat

(2011) Jie Ding et al.   CELLULAR AND MOLECULAR NEUROBIOLOGY

Conventional brain MRI in neuromyelitis optica

(2011) J. A. Cabrera-Gomez et al.   EUROPEAN JOURNAL OF NEUROLOGY

Epigallocatechin-3-gallate (EGCG) for Clinical Trials: More Pitfalls than Promises?

(2011) Derliz Mereles et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Expression of mutant alpha-synuclein modulates microglial phenotype in vitro

(2011) Lalida Rojanathammanee et al.   Journal of Neuroinflammation

Progressive multifocal leukoencephalopathy and natalizumab

(2011) Kerstin Hellwig et al.   JOURNAL OF NEUROLOGY

Dietary supplementation with high dose of epigallocatechin-3-gallate promotes inflammatory response in mice

(2011) Munkyong Pae et al.   JOURNAL OF NUTRITIONAL BIOCHEMISTRY

Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: Results from 211 lumbar punctures

(2011) S. Jarius et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Fatigue in multiple sclerosis: which patient should be referred to a sleep specialist?

(2011) Christian Veauthier et al.   Multiple Sclerosis Journal

Delayed fingolimod-associated asystole

(2011) Patricio S Espinosa et al.   Multiple Sclerosis Journal

Prevention and treatment of MS: studying the effects of vitamin D

(2011) Kassandra L Munger et al.   Multiple Sclerosis Journal

Sunlight exposure and sun sensitivity associated with disability progression in multiple sclerosis

(2011) MB D’hooghe et al.   Multiple Sclerosis Journal

Long-term safety profile of mitoxantrone in a French cohort of 802 multiple sclerosis patients: a 5-year prospective study

(2011) E Le Page et al.   Multiple Sclerosis Journal

Massive astrocyte destruction in neuromyelitis optica despite natalizumab therapy

(2011) MH Barnett et al.   Multiple Sclerosis Journal

Development of extensive brain lesions following fingolimod (FTY720) treatment in a patient with neuromyelitis optica spectrum disorder

(2011) Ju-Hong Min et al.   Multiple Sclerosis Journal

Critical appraisal of animal models of multiple sclerosis

(2011) David Baker et al.   Multiple Sclerosis Journal

Fatigue in multiple sclerosis is closely related to sleep disorders: a polysomnographic cross-sectional study

(2011) C Veauthier et al.   Multiple Sclerosis Journal

Intrathecal EBV antibodies are part of the polyspecific immune response in multiple sclerosis

(2011) C. Otto et al.   NEUROLOGY

Small-fiber neuropathy in patients with ALS

(2011) J. Weis et al.   NEUROLOGY

Functional changes in Duchenne muscular dystrophy: A 12-month longitudinal cohort study

(2011) E. Mazzone et al.   NEUROLOGY

Azathioprine: Tolerability, efficacy, and predictors of benefit in neuromyelitis optica

(2011) C. Costanzi et al.   NEUROLOGY

Sodium (23Na) MRI detects elevated muscular sodium concentration in Duchenne muscular dystrophy

(2011) M.- A. Weber et al.   NEUROLOGY

Sun exposure and vitamin D are independent risk factors for CNS demyelination

(2011) R. M. Lucas et al.   NEUROLOGY

(−)-Epigallocatechin-3-gallate Protects Against Neuronal Cell Death and Improves Cerebral Function After Traumatic Brain Injury in Rats

(2011) Tatsuki Itoh et al.   NEUROMOLECULAR MEDICINE

The chemistry and biotransformation of tea constituents

(2011) Shengmin Sang et al.   PHARMACOLOGICAL RESEARCH

The Epidemiology of Multiple Sclerosis in Scotland: Inferences from Hospital Admissions

(2011) Adam E. Handel et al.   PLoS One

Smoking and Multiple Sclerosis: An Updated Meta-Analysis

(2011) Adam E. Handel et al.   PLoS One

Switching Multiple Sclerosis Patients with Breakthrough Disease to Second-Line Therapy

(2011) Tamara Castillo-Trivino et al.   PLoS One

Functional Characterization of Aquaporin-4 Specific T Cells: Towards a Model for Neuromyelitis Optica

(2011) Sudhakar Reddy Kalluri et al.   PLoS One

Metabolic Changes in the Visual Cortex Are Linked to Retinal Nerve Fiber Layer Thinning in Multiple Sclerosis

(2011) Caspar F. Pfueller et al.   PLoS One

Association of Retinal and Macular Damage with Brain Atrophy in Multiple Sclerosis

(2011) Jan Dörr et al.   PLoS One

Comparative Brain Stem Lesions on MRI of Acute Disseminated Encephalomyelitis, Neuromyelitis Optica, and Multiple Sclerosis

(2011) Zhengqi Lu et al.   PLoS One

Dysregulated LRRK2 Signaling in Response to Endoplasmic Reticulum Stress Leads to Dopaminergic Neuron Degeneration in C. elegans

(2011) Yiyuan Yuan et al.   PLoS One

The Use of Serum Glial Fibrillary Acidic Protein Measurements in the Diagnosis of Neuromyelitis Optica Spectrum Optic Neuritis

(2011) Mithu Storoni et al.   PLoS One

Neuroprotective Effect of Combination Therapy of Glatiramer Acetate and Epigallocatechin-3-Gallate in Neuroinflammation

(2011) Katja Herges et al.   PLoS One

Intravenous Neuromyelitis Optica Autoantibody in Mice Targets Aquaporin-4 in Peripheral Organs and Area Postrema

(2011) Julien Ratelade et al.   PLoS One

Exercise in multiple sclerosis -- an integral component of disease management

(2011) Andrea Döring et al.   EPMA Journal

Neuromyelitis Optica Treatment

(2010) Denis Bernardi Bichuetti et al.   ARCHIVES OF NEUROLOGY

Interferon Beta Treatment in Neuromyelitis Optica

(2010) Jacqueline Palace et al.   ARCHIVES OF NEUROLOGY

Efficacy and Safety of Mitoxantrone in Patients With Highly Relapsing Neuromyelitis Optica

(2010) Su-Hyun Kim et al.   ARCHIVES OF NEUROLOGY

Pro-oxidative activities and dose–response relationship of (−)-epigallocatechin-3-gallate in the inhibition of lung cancer cell growth: a comparative study in vivo and in vitro

(2010) Guang-Xun Li et al.   CARCINOGENESIS

Mechanisms underlying iron and copper ions toxicity in biological systems: Pro-oxidant activity and protein-binding effects

(2010) María Eugenia Letelier et al.   CHEMICO-BIOLOGICAL INTERACTIONS

Patterns of retinal nerve fiber layer loss in multiple sclerosis patients with or without optic neuritis and glaucoma patients

(2010) Markus Bock et al.   CLINICAL NEUROLOGY AND NEUROSURGERY

The natural history of Caenorhabditis elegans

(2010) Marie-Anne Félix et al.   CURRENT BIOLOGY

Epigallocatechin-3-gallate and postprandial fat oxidation in overweight/obese male volunteers: a pilot study

(2010) F Thielecke et al.   EUROPEAN JOURNAL OF CLINICAL NUTRITION

Epigallocatechin-3-gallate protects motor neurons and regulates glutamate level

(2010) Jixu Yu et al.   FEBS LETTERS

Inhibition of inducible nitric oxide synthase expression and cell death by (−)-epigallocatechin-3-gallate, a green tea catechin, in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson’s disease

(2010) Ji Seon Kim et al.   JOURNAL OF CLINICAL NEUROSCIENCE

Cerebrospinal fluid antibodies to aquaporin-4 in neuromyelitis optica and related disorders: frequency, origin, and diagnostic relevance

(2010) Sven Jarius et al.   Journal of Neuroinflammation

Living with multiple sclerosis: longitudinal changes in employment and the importance of symptom management

(2010) Rex D. Simmons et al.   JOURNAL OF NEUROLOGY

Metals, oxidative stress and neurodegenerative disorders

(2010) Klaudia Jomova et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

Correlation of self-assessed fatigue and alertness in multiple sclerosis

(2010) Nicholetta Weinges-Evers et al.   Multiple Sclerosis Journal

Time domain and spectral domain optical coherence tomography in multiple sclerosis: a comparative cross-sectional study

(2010) Markus Bock et al.   Multiple Sclerosis Journal

Improving the translational hit of experimental treatments in multiple sclerosis

(2010) Hanna M Vesterinen et al.   Multiple Sclerosis Journal

Treatment effects of immunomodulatory therapies at different stages of multiple sclerosis in short-term trials

(2010) D. Bates   NEUROLOGY

IFN -1b may severely exacerbate Japanese optic-spinal MS in neuromyelitis optica spectrum

(2010) J. Shimizu et al.   NEUROLOGY

Protective effect of green tea (-)-epigallocatechin-3-gallate against the monoamine oxidase B enzyme activity increase in adult rat brains

(2010) Shyh-Mirn Lin et al.   NUTRITION

Molecular Mechanisms and Potential Therapeutical Targets in Huntington's Disease

(2010) Chiara Zuccato et al.   PHYSIOLOGICAL REVIEWS

Motor Neuron Synapse and Axon Defects in a C. elegans Alpha-Tubulin Mutant

(2010) Renee Baran et al.   PLoS One

Microglia Acquire Distinct Activation Profiles Depending on the Degree of α-Synuclein Neuropathology in a rAAV Based Model of Parkinson's Disease

(2010) Vanesa Sanchez-Guajardo et al.   PLoS One

Patterns of Antibody Binding to Aquaporin-4 Isoforms in Neuromyelitis Optica

(2010) Simone Mader et al.   PLoS One

Dual Beneficial Effects of (-)-Epigallocatechin-3-Gallate on Levodopa Methylation and Hippocampal Neurodegeneration: In Vitro and In Vivo Studies

(2010) Ki Sung Kang et al.   PLoS One

Immunodominant T Cell Determinants of Aquaporin-4, the Autoantigen Associated with Neuromyelitis Optica

(2010) Patricia A. Nelson et al.   PLoS One

Glial Innate Immunity Generated by Non-Aggregated Alpha-Synuclein in Mouse: Differences between Wild-type and Parkinson's Disease-Linked Mutants

(2010) Cintia Roodveldt et al.   PLoS One

EGCG remodels mature α-synuclein and amyloid-β fibrils and reduces cellular toxicity

(2010) Jan Bieschke et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Lower motor neuron loss in multiple sclerosis and experimental autoimmune encephalomyelitis

(2009) Johannes Vogt et al.   ANNALS OF NEUROLOGY

Treatment of Neuromyelitis Optica With Mycophenolate Mofetil

(2009) Anu Jacob et al.   ARCHIVES OF NEUROLOGY

Neuroprotective effect of epigallocatechin-3-gallate against β-amyloid-induced oxidative and nitrosative cell death via augmentation of antioxidant defense capacity

(2009) Chang-Yul Kim et al.   ARCHIVES OF PHARMACAL RESEARCH

Protection of dystrophic muscle cells with polyphenols from green tea correlates with improved glutathione balance and increased expression of 67LR, a receptor for (−)-epigallocatechin gallate

(2009) Olivier M. Dorchies et al.   BIOFACTORS

Neuroprotective Effects of (−)-Epigallocatechin-3-gallate on Aging Mice Induced by D-Galactose

(2009) Miao He et al.   BIOLOGICAL & PHARMACEUTICAL BULLETIN

Oral pre-treatment with epigallocatechin gallate in 6-OHDA lesioned rats produces subtle symptomatic relief but not neuroprotection

(2009) Katherine R. Leaver et al.   BRAIN RESEARCH BULLETIN

Green tea extract decreases muscle pathology and NF-κB immunostaining in regenerating muscle fibers of mdx mice

(2009) Nicholas P. Evans et al.   CLINICAL NUTRITION

Oxidative Stress and Neurodegenerative Diseases: A Review of Upstream and Downstream Antioxidant Therapeutic Options

(2009) Bayani Uttara et al.   Current Neuropharmacology

Effect of lycopene and epigallocatechin-3-gallate against 3-nitropropionic acid induced cognitive dysfunction and glutathione depletion in rat: A novel nitric oxide mechanism

(2009) Puneet Kumar et al.   FOOD AND CHEMICAL TOXICOLOGY

Green tea EGCG suppresses T cell proliferation through impairment of IL-2/IL-2 receptor signaling

(2009) Dayong Wu et al.   FREE RADICAL BIOLOGY AND MEDICINE

Animal models of multiple sclerosis for the development and validation of novel therapies – potential and limitations

(2009) Eilhard Mix et al.   JOURNAL OF NEUROLOGY

Green Tea (-)-Epigallocatechin-3-Gallate Inhibits β-Amyloid-Induced Cognitive Dysfunction through Modification of Secretase Activity via Inhibition of ERK and NF-κB Pathways in Mice

(2009) Jae Woong Lee et al.   JOURNAL OF NUTRITION

Green tea polyphenol (−)-epigallocatechin gallate reduces matrix metalloproteinase-9 activity following transient focal cerebral ischemia

(2009) Jong-Wook Park et al.   JOURNAL OF NUTRITIONAL BIOCHEMISTRY

Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management

(2009) Katharine Bushby et al.   LANCET NEUROLOGY

Fatigued patients with multiple sclerosis have impaired central muscle activation

(2009) AK Andreasen et al.   Multiple Sclerosis Journal

Attention Network Test reveals alerting network dysfunction in multiple sclerosis

(2009) Carsten Urbanek et al.   Multiple Sclerosis Journal

Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci

(2009) Philip L De Jager et al.   NATURE GENETICS

The mechanism of action of glatiramer acetate treatment in multiple sclerosis

(2009) M. K. Racke et al.   NEUROLOGY

SEVERE CARDIAC FAILURE IN A PATIENT WITH MULTIPLE SCLEROSIS FOLLOWING LOW-DOSE MITOXANTRONE TREATMENT

(2009) J. Dorr et al.   NEUROLOGY

Neuroendocrine Disturbances in Huntington's Disease

(2009) Nadine Saleh et al.   PLoS One

The Causal Cascade to Multiple Sclerosis: A Model for MS Pathogenesis

(2009) Douglas S. Goodin   PLoS One

Vitamin D Status Is Positively Correlated with Regulatory T Cell Function in Patients with Multiple Sclerosis

(2009) Joost Smolders et al.   PLoS One

Green and Black Tea Consumption and Risk of Stroke

(2009) Lenore Arab et al.   STROKE

Treatment of Neuromyelitis Optica With Rituximab

(2008)   ARCHIVES OF NEUROLOGY

Effects of epigallocatechin-3-gallate on mitochondrial integrity and antioxidative enzyme activity in the aging process of human fibroblast

(2008) Qingying Meng et al.   FREE RADICAL BIOLOGY AND MEDICINE

Significant longevity-extending effects of EGCG on Caenorhabditis elegans under stress

(2008) Longze Zhang et al.   FREE RADICAL BIOLOGY AND MEDICINE

Subcutaneous injection, from birth, of epigallocatechin-3-gallate, a component of green tea, limits the onset of muscular dystrophy in mdx mice: a quantitative histological, immunohistochemical and electrophysiological study

(2008) Yoshiko Nakae et al.   HISTOCHEMISTRY AND CELL BIOLOGY

Attenuation of senescence-induced oxidative exacerbations in aged rat brain by (−)-epigallocatechin-3-gallate

(2008) Ravichandran Srividhya et al.   INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE

Endurance capacity in maturing mdx mice is markedly enhanced by combined voluntary wheel running and green tea extract

(2008) Jarrod A. Call et al.   JOURNAL OF APPLIED PHYSIOLOGY

Basic and escalating immunomodulatory treatments in multiple sclerosis: Current therapeutic recommendations

(2008) et al.   JOURNAL OF NEUROLOGY

Green tea polyphenol (-)-epigallocatechin gallate reduces neuronal cell damage and up-regulation of MMP-9 activity in hippocampal CA1 and CA2 areas following transient global cerebral ischemia

(2008) Jong-Wan Park et al.   JOURNAL OF NEUROSCIENCE RESEARCH

Multiple sclerosis

(2008) Alastair Compston et al.   LANCET

Stroke

(2008) Geoffrey A Donnan et al.   LANCET

Smoking worsens the prognosis in multiple sclerosis

(2008) P Sundström et al.   Multiple Sclerosis Journal

Smoking and tea consumption delay onset of Parkinson's disease

(2008) Boris Kandinov et al.   PARKINSONISM & RELATED DISORDERS

Epigallocatechin Gallate from Green Tea (Camellia sinensis) Increases Lifespan and Stress Resistance inCaenorhabditis elegans

(2008) Sami Abbas et al.   PLANTA MEDICA

Molecular modelling study of the mechanism of high-potency inhibition of human catechol-O-methyltransferase by (–)-epigallocatechin-3-O-gallate

(2008) B. T. Zhu et al.   XENOBIOTICA

Therapeutic effect of epigallocatechin-3-gallate in a mouse model of colitis

(2007) Patricia A. Abboud et al.   EUROPEAN JOURNAL OF PHARMACOLOGY